Loading company…
Israeli biopharmaceutical company developing mitochondrial health as a therapy for neurodegenerative diseases.
Mitoconix Bio Ltd. develops mitochondrial health as a disease-modifying therapeutic for neurodegenerative diseases. Founded in 2016 and based in Ness Ziona, Israel, the company is at Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in